Loading
A phase 2 trial of ITIL-168 run by Instil Bio, terminated.
ITIL-168 in Advanced Melanoma is a phase 2 interventional study registered as NCT05050006 by Instil Bio, with 29 participants enrolled, started 2021-10-07. Conditions recorded: Advanced Cutaneous Melanoma. Interventions recorded: ITIL-168.
Shares ITIL-168, Instil Bio and the tag pipeline.
Shares Instil Bio and the tag pipeline.
Shares Melanoma and the tag pipeline.
Shares Melanoma and the tag pipeline.
Shares Melanoma and the tag pipeline.
Shares Melanoma and the tag pipeline.
Shares Melanoma and the tag pipeline.
Shares Melanoma and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/